Create an "off-the-shelf" JC virus (JCV)-specific T cell therapy for progressive multifocal leukoencephalopathy (PML) patients who are immunocompromised and unable to adequately immune reconstitute.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: